Toggle Summary 02 Sep. 2024
JPLs release copy of their Ninth Report to the Grand Court of the Caymans Islands
Toggle Summary 12 Aug. 2024
The JPLs summons (as amended) was part-heard on 30 July 2024 and resulted in various orders by the Grand Court of the Cayman Islands. On 9 August 2024, a notice was issued to shareholders providing, inter alia, details of the outcome of the hearing, together with a copy of the Court orders.
Toggle Summary 18 Jul. 2024
On 18 July 2024, the JPLs issued correspondence to shareholders providing notice of an amendment to the Summons to seek Court approval of the proposed terms of remuneration. A sealed version of the amended summons was received from the Court Registry on 17 July 2024. Please click here for a copy of the notice and the Court orders
Toggle Summary 03 Jun. 2024
JPLs release copy of their Eighth Report to the Grand Court of the Cayman Islands
Toggle Summary 29 May. 2024
i. On 13 May 2024, the JPLs filed a summons for court approval of the terms of their remuneration agreement and their remuneration for the Fee Approval Period pursuant to section 109(2) of the Companies Act and the Insolvency Practitioners' Regulations (2023 Consolidation) (the "Summons"). The Summons has been listed for hearing at 10am on 30 July 2024.[email protected] .
Toggle Summary 19 Mar. 2024
JPL's announce EGM to be held on 16 April 2024 for the purpose of considering and, if thought fit, passing resolutions in respect to the JPL's proposed terms of remuneration and the JPL's remuneration and disbursements for the period from 22 September 2022 to 30 September 2023. Further details regarding the proposals are set out in the i) Notice of EGM ii) Proxy Card iii) Proxy Statement and iv) Rules of Conduct . Note that only verified shareholders will be able to vote at the EGM.
Toggle Summary 08 Mar. 2024
JPLs release copy of their Seventh Report to the Grand Court of the Cayman Islands
Toggle Summary 01 Dec. 2023
JPLs release copy of their Sixth Report to the Grand Court of the Cayman Islands
Toggle Summary 04 Sep. 2023
JPLs release copy of their Fifth Report to the Grand Court of the Cayman Islands
Toggle Summary 01 Jun. 2023
JPLs release copy of their Fourth Report to the Grand Court of the Cayman Islands
Toggle Summary 02 Mar. 2023
JPLs release copy of their Third Report to the Grand Court of the Cayman Islands
Toggle Summary 02 Dec. 2022
JPLs release copy of their Second Report to the Grand Court of the Cayman Islands
Toggle Summary 31 Oct. 2022
JPLs release copy of their First Report to the Grand Court of the Cayman Islands
Toggle Summary 26 Sep. 2022
Press Release in respect of the JPLs appointment
Toggle Summary 16 Aug. 2022
Global Cord Blood Corporation Files Annual Report on Form 20-F
Toggle Summary 06 Jul. 2022
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
Toggle Summary 05 Jul. 2022
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Toggle Summary 16 Jun. 2022
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
Toggle Summary 16 Jun. 2022
Global Cord Blood Corporation Announces Purported EGM Is Not Validly Convened
Toggle Summary 10 May. 2022
Global Cord Blood Corporation Announces Receipt of Blue Ocean Petition
Toggle Summary 29 Apr. 2022
Global Cord Blood Corporation Announces Entry into Cell Therapy Market by Acquiring Cellenkos and Its Products Rights
Toggle Summary 28 Feb. 2022
Global Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2022
Toggle Summary 23 Feb. 2022
Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results
